Blackstone Life Sciences will provide $400 million to support development of duvakitug, a human monoclonal antibody targeting TL1ADuvakitug is currently in phase 3...
A memoir that blends worldly travels, romance, and personal insight into a remarkable story.
Cookstown, New Jersey, USA – WEBWIRE – Friday, February 6,...
Technology group Wrtsil will upgrade the Wrtsil RT-flex main engines on two bulk carrier vessels owned by Turkey-based Ulusoy Sealines. The planned engine...
Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced that Novartis...
Blackstone Life Sciences and Anthos Therapeutics, Inc. (Anthos or the company), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of...
